Search results

The online distribution of prescription‐only pharmaceutical products raises serious legal and regulatory issues, including how governments, agencies, or organizations will regulate and monitor such activities, particularly when the distributors are offshore Web sites. This paper discusses the current regulatory environment for marketing prescription‐only drugs online and distributing them across national borders, along with product liability issues. Four hypothetical scenarios focus on key legal and regulatory issues.

Use of off-license medicines in forensic mental health settings is common and unlicensed drugs are sometimes prescribed. Despite their responsibility for administering medicines little is known about how mental health nurses view these practices. The paper aims to discuss these issues.

In total, 50 mental health nurses working in low and medium secure adolescent and adult mental health wards were presented with a clinical vignette about administration of unlicensed and off-license medicines. Semi-structured interviews about their likely clinical response to, and feelings about, this practice were conducted. Interview data were subject to a thematic analysis.

Analysis revealed six themes: status of unlicensed/off-label medicines; legality of administering unlicensed medicines; professional standards around administering unlicensed medicines; finding out more about unlicensed medicines; trusting medical colleagues; and decision making in uncertain cases.

Forensic mental health nurses take a pragmatic approach to the practice of administering unlicensed medicines and most are aware of their professional responsibilities.

This study provides the first evidence to inform the development of training for forensic mental health nurses about an issue that is common in forensic mental health practice.

This paper aims to explore the link between dangerous driving and other criminal behaviour.

Arksey and O’Malley’s (2005) five-step process for scoping reviews to identify, summarise and classify identified literature was used. Within the 30-year timeframe (1990–2019), 12 studies met the inclusion criteria.

This review indicates that individuals who commit certain driving offences are more likely to also have a general criminal history. In particular, driving under the influence, driving unlicensed and high-range speeding offences were associated with other forms of criminal behaviour. Seven of the studies mentioned common criminological theories; however, they were not integrated well in the analysis. No studies used explanatory psychosocial theories that investigate social and contextual factors.

Future research in this area would benefit from exploring individual and social influences that contribute to criminal behaviour in both contexts.

There is the potential to develop an information-led policing approach to improve safety on the roads and reduce wider offending behaviour. However, it is critical that road policing officers continue to focus on ensuring the road system is as safe as possible for users.

Criminal behaviour on the roads is often seen as a separate from other types of offending. This paper explores if, and how, these two types of offending are linked.

This study aims to measure the global research landscape on Pharmacovigilance (PV) indexed in the Scopus database for six years period spanning from 2015 to 2020. The study examines growth rate, author productivity and prominent authors, institutions and countries.

The research literature on PV published globally and indexed in the Scopus core collection database was retrieved using the search string “pharmacovigilance” as per the Medical List of Subject Heading. A total of 1,272 documents were retrieved based on the query set. Quantitative and visualization technologies were used for data analysis and interpretation. Network visualization maps including research collaboration of authors, journals, institutions and countries were created by using the VOSviewer program.

A total of 1,272 global scientific research output on PV were retrieved with an annual average growth rate of 21.70% and with a proportion of 3.84% compound annual growth rate. The relative growth rate for the world’s PV publications decreased gradually from the rate of 0.71 to 0.20. On the other hand, the doubling time (DT) of PV publications displays an increasing trend from the rate of 0.97 to 3.46. The mean relative growth and DT of PV publication for six years is 0.32 and 1.87, respectively. The global publications on PV registered a total of 6,387 citations with an average citation impact of 5.02 citations per paper. The average number of authors per paper was 0.76 and the average productivity per author was 1.33. The most productive journal was Drug Safety with a total of 74 papers. France has the highest number of publications with a total of 251 papers accounting for 19.73%. Uppsala Monitoring Center, Sweden dominated in research productivity on PV with a proportion of 1.89% papers. There is a considerable research output in the areas of medicine accounting for 77.43% of total publications.

The outcome of the study may help regulators, drug manufacturers, medical scientists and health-care professionals to identify the progress in PV research. In addition, it will also help to identify the prolific authors, journals, institutions and countries/territories in the development of research.

PV across the globe has become an important public health issue concerning to regulators, drug manufacturers and health-care professionals, therefore, it is feasible to know the research landscape to safeguard of public health.

The investigation is the first attempt to the scientometric assessment of PV research output at the global level.

Even those most skilled in the art of diagnosis occasionally need to be reminded that common things occur most commonly; it saves them chasing obscure signs to uncommon conclusions. Having spent several uncomfortable days in snuffling and snivelling, sneezing, streaming; sequestered with the piles of wet handkerchiefs mounting, with which we believe we have developed entirely novel and hitherto untried methods of nose‐drying; in all this, we felt the urge to write a little to those who search for uncommon things in food about that commonest of all common things—the common cold! This may not be so important after all, as there has at last been developed satisfactory culture‐techniques for the common cold viruses and cold vaccines are now distinctly probable, so that for generations unborn, the common cold may become an uncommon infection. Who knows?

The purpose of this paper is to assess the current legal framework on money laundering control in the insurance sector. Essentially, this examination is premised on the interrogation of whether it is still appropriate for Mauritius to apply such stringent, opaque and unyielding Anti-Money Laundering/Combating Financing of Terrorism norms and rules on general insurance when developed nations such as the UK and Singapore have done away with them for a more effective combat against money laundering. It would also be assessed why the financial services commission (FSC) is not able to draw inspiration from its British and Singaporean counterparts in fighting money laundering more effectively.

This paper uses the doctrinal legal research methodology which is colloquially described as “black-letter law” approach. It is backed up by a contextual legal analysis that is based on an analysis of relevant legal provisions. It relies ground experience from the insurance industry through the experience of the authors. A comparative approach is used with Singapore and the UK as case studies given that there are significant commonalities to the Mauritian jurisdiction as well as useful differences.

It is observed that a move towards a de-regulation of the legal framework on money laundering in the insurance sector with a more relaxed approach is more effective for the Mauritian insurance sector. Evidence is drawn from the Singaporean and British models. A re-structuring of the FSC of Mauritius is also warranted for such an approach to be adopted.

This paper is among the first academic contribution that proposes a de-regulation and the adoption of a relaxed approach of and by the Mauritian Insurance Industry for a more effective combat against money laundering. It serves as a legal foundational basis for further research in this direction.

Rarely have studies on the acquisition of knowledge in internationalisation focused on institutional knowledge. The purpose of this paper is, therefore, to investigate the acquisition of this knowledge, and its assimilation and exploitation processes in internationalisation.

The paper utilises ten longitudinal revelatory case studies built from multiple semi-structured interviews conducted with three different firm types of small- and medium-sized enterprise (SMEs) in the pharmaceutical industry and secondary documents to which the researchers obtained proprietary access.

The study enhances the conceptual understanding of the institutional learning process in internationalisation by, for the first time, developing a framework to characterise this process. The study explores and identifies multiple types of institutional knowledge required, the sequencing of their acquisition, sources and learning methods utilised. It also discusses transferability of this learning across foreign markets and firms’ absorptive capacity for that knowledge. Regulatory-specific product knowledge, found to be the most important type required, appeared to affect significantly both market selection and mode of entry, and when acquired insufficiently, prevented internationalisation.

While the sample size is relatively small, and sector-specific, the findings were consistent across all the SME firms and firm types. They may also be generalisable to other sectors, firm sizes such as MNEs and types, particularly those which are knowledge-based or highly regulated, given that similar institutional knowledge and processes of acquisition are necessary for firms of all sizes in internationalisation.

International marketing managers will gain valuable insights, based on a framework proven to propel firms to successful internationalisation, upon how to plan, organise, manage and match their institutional knowledge-seeking and learning activities with their firms’ internal capabilities, staffing and other resources in an effective and timely manner.

This study contributes to the conceptual understanding of the institutional knowledge learning process in the internationalisation.

Sleep disorders are extremely common in children and young people, and even more so in those with developmental disabilities. This client subgroup may prove refractory to standard behavioural and other psychosocial interventions that usually help and it is frequent for clinicians to resort to medication approaches given the high levels of personal and family distress that result. There is a need not only for further well structured research in this field but also for efforts to tackle the frequent relative neglect by clinicians of more researched and considered approaches. This review examines these issues selectively, focusing on important clinical issues and predicaments, and attempts a start at an evidence‐based background for practical and rational prescribing in this area of common childhood psychopathology.